326 related articles for article (PubMed ID: 35395587)
1. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.
Curry TE; Song L; Wheeler SE
Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-induced alterations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) in the chicken ovary.
Wolak D; Hrabia A
Theriogenology; 2020 May; 148():208-215. PubMed ID: 31753476
[TBL] [Abstract][Full Text] [Related]
4. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Effect of eCG treatment on gene expression of selected matrix metalloproteinases (MMP-2, MMP-7, MMP-9, MMP-10, and MMP-13) and the tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary.
Wolak D; Sechman A; Hrabia A
Anim Reprod Sci; 2021 Jan; 224():106666. PubMed ID: 33260067
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Matrix Metalloproteinases and their Inhibitors in Bovine Cystic Ovarian Disease.
Peralta MB; Baravalle ME; Belotti EM; Stassi AF; Salvetti NR; Ortega HH; Rey F; Velázquez MML
J Comp Pathol; 2017; 156(2-3):191-201. PubMed ID: 27993358
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
10. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
11. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
12. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
[TBL] [Abstract][Full Text] [Related]
14. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
Hrabia A; Socha JK; Sechman A
Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
16. MMPS and TIMPS in ovarian physiology and pathophysiology.
Goldman S; Shalev E
Front Biosci; 2004 Sep; 9():2474-83. PubMed ID: 15353300
[TBL] [Abstract][Full Text] [Related]
17. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
Robinson LL; Sznajder NA; Riley SC; Anderson RA
Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
[TBL] [Abstract][Full Text] [Related]
19. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
[TBL] [Abstract][Full Text] [Related]
20. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
